Jun 30, 2023

Y-mAbs Q2 2023 Earnings Report

Y-mAbs reported financial results for the second quarter of 2023, marked by continued revenue growth of DANYELZA and international expansion with regulatory approval in Brazil.

Key Takeaways

Y-mAbs reported DANYELZA net product revenues of $20.8 million for the quarter ended June 30, 2023, representing an increase of 112% over the comparable period of 2022. The company's cash and cash equivalents are expected to support operations into 2026.

DANYELZA net product revenues increased by 112% compared to the same quarter last year.

International revenues included $3.5 million from a China commercial launch inventory stocking order.

DANYELZA has been delivered to 56 centers across the U.S., a sequential increase of 6% since the first quarter of 2023.

Net loss for the second quarter ended June 30, 2023, was $6.3 million, compared to a net loss of $41.1 million for the quarter ended June 30, 2022.

Total Revenue
$20.8M
Previous year: $10.8M
+92.2%
EPS
-$0.14
Previous year: -$0.94
-85.1%
Gross Profit
$16.1M
Previous year: $9.56M
+68.5%
Cash and Equivalents
$87.9M
Previous year: $134M
-34.3%
Total Assets
$132M
Previous year: $165M
-19.8%

Y-mAbs

Y-mAbs

Forward Guidance

Management reiterates its full year 2023 financial guidance, as updated on May 8, 2023.